Last Updated: May 10, 2026

Drugs Containing Excipient (Inactive Ingredient) FD&C YELLOW NO. 6 ALUMINUM LAKE


✉ Email this page to a colleague

« Back to Dashboard


Generic drugs containing FD&C YELLOW NO. 6 ALUMINUM LAKE excipient

FD&C Yellow No. 6 Aluminum Lake: Market Dynamics and Financial Trajectory

Last updated: February 19, 2026

What is FD&C Yellow No. 6 Aluminum Lake?

FD&C Yellow No. 6 Aluminum Lake (CAS No. 15706-26-8) is a synthetic organic colorant approved by the U.S. Food and Drug Administration (FDA) for use in food, drugs, and cosmetics. It is a water-insoluble lake pigment derived from FD&C Yellow No. 6 (Sunset Yellow FCF) by precipitation onto an aluminum hydroxide substrate. This process enhances its stability and disperses properties, making it suitable for a range of pharmaceutical applications, particularly in solid dosage forms like tablets and capsules. The colorant provides a vibrant yellow hue and is utilized to differentiate products, indicate dosage, or improve product aesthetics. Its regulatory status is governed by 21 CFR Part 74.1706 in the United States.

What are the Primary Pharmaceutical Applications?

The primary pharmaceutical applications for FD&C Yellow No. 6 Aluminum Lake involve its use as a colorant in solid oral dosage forms. These include:

  • Tablets: Providing distinctive color for identification and branding.
  • Capsules: Coloring the capsule shell or the contents within.
  • Coatings: Incorporated into film coatings for tablets to enhance visual appeal and patient compliance.

Beyond oral solids, it can also be found in certain topical preparations and pharmaceutical inks used for tablet printing. The choice of FD&C Yellow No. 6 Aluminum Lake is driven by its color intensity, lightfastness, and chemical inertness within typical pharmaceutical formulations.

What is the Global Market Size and Projected Growth?

The global market for pharmaceutical excipients, including colorants like FD&C Yellow No. 6 Aluminum Lake, is substantial. While specific market data for FD&C Yellow No. 6 Aluminum Lake is often aggregated within broader colorant or excipient segments, industry reports indicate consistent growth. The global pharmaceutical excipients market was valued at approximately $10.4 billion in 2022 and is projected to reach around $15.7 billion by 2029, exhibiting a compound annual growth rate (CAGR) of approximately 6.1% [1].

Within this broad market, colorants represent a smaller but vital segment. Demand for FD&C Yellow No. 6 Aluminum Lake is influenced by the growth of the generic drug market, the increasing prevalence of chronic diseases requiring long-term medication, and the rising consumer demand for aesthetically pleasing pharmaceuticals. Emerging markets in Asia-Pacific and Latin America, with their expanding healthcare infrastructure and pharmaceutical manufacturing capabilities, are also contributing to market expansion.

Which Key Market Drivers Influence Demand?

Several key market drivers influence the demand for FD&C Yellow No. 6 Aluminum Lake in the pharmaceutical industry:

  • Growth in Generic Pharmaceuticals: The expiration of patents for blockbuster drugs leads to increased production of generics, many of which require distinct colorants for differentiation and branding, driving demand for approved dyes and lakes [2].
  • Patient Compliance and Safety: Consistent and recognizable coloring aids patients in identifying the correct medication and dosage, improving adherence to treatment regimens, especially for individuals with multiple prescriptions or visual impairments [3].
  • Regulatory Stringency: While regulatory approval is a prerequisite, the ongoing adherence to stringent FDA and other international regulatory body standards for purity, safety, and labeling of colorants ensures continued market access for compliant products like FD&C Yellow No. 6 Aluminum Lake.
  • Product Differentiation and Branding: Pharmaceutical companies utilize color to establish brand identity and distinguish their products from competitors, a practice that sustains demand for a diverse palette of approved colorants.
  • Advancements in Drug Delivery Systems: The development of new oral dosage forms, such as orally disintegrating tablets and chewable tablets, often requires specialized excipients, including colorants that can withstand processing and provide visual appeal.

What are the Major Challenges Affecting the Market?

The market for FD&C Yellow No. 6 Aluminum Lake faces several significant challenges:

  • Raw Material Price Volatility: The cost of raw materials used in the synthesis of FD&C Yellow No. 6 Aluminum Lake can fluctuate due to global supply chain disruptions, geopolitical instability, and the pricing of petrochemical feedstocks, impacting manufacturing costs and profit margins.
  • Stringent Regulatory Landscape: Evolving regulatory requirements, including stricter limits on impurities and potential allergens, can necessitate reformulation or increased testing, leading to higher compliance costs. Regions may have differing approval processes and accepted colorant lists, creating market access hurdles [4].
  • Competition from Alternative Colorants: The market sees competition from other synthetic colorants, natural colorants, and innovative coloring technologies. While FD&C Yellow No. 6 Aluminum Lake offers specific advantages, the demand for "clean label" or natural alternatives is growing.
  • Supply Chain Vulnerabilities: Disruptions in global supply chains, as evidenced by recent events, can impact the availability and timely delivery of FD&C Yellow No. 6 Aluminum Lake, affecting pharmaceutical manufacturers' production schedules.
  • Public Perception and "Free-From" Trends: A segment of consumers and formulators are increasingly seeking pharmaceuticals with fewer synthetic ingredients. While FD&C Yellow No. 6 Aluminum Lake is approved and widely used, this trend could indirectly impact demand for synthetic colorants if viable natural alternatives become more prevalent and cost-effective.

Which Key Companies are Leading the Market?

The market for FD&C Yellow No. 6 Aluminum Lake is served by several key players specializing in pharmaceutical excipients and colorants. These companies often have established supply chains, robust quality control systems, and extensive regulatory expertise. Leading companies include:

  • Sensient Technologies Corporation: A global manufacturer and marketer of colors, flavors, and fragrances, with a significant presence in pharmaceutical ingredients.
  • Chromatech: Specializing in custom color solutions for the pharmaceutical and nutraceutical industries.
  • Eastman Chemical Company: Offers a range of specialty materials, including colorants for various applications.
  • Milliplexus: A provider of pharmaceutical excipients and active pharmaceutical ingredients.
  • fornecedores de corantes farmacĂȘuticos na Ásia: Numerous companies based in China and India are significant suppliers of colorants and excipients, often competing on price and volume.

These companies compete on product quality, regulatory compliance, supply chain reliability, and customer service.

What is the Competitive Landscape and Strategic Initiatives?

The competitive landscape is characterized by a mix of large, diversified chemical companies and specialized excipient manufacturers. Companies focus on several strategic initiatives to maintain and grow market share:

  • Product Quality and Purity: Ensuring consistent high purity and meeting all pharmacopoeial standards (e.g., USP, EP) is paramount. Manufacturers invest in advanced quality control and assurance processes.
  • Regulatory Support: Providing comprehensive documentation and regulatory support to pharmaceutical clients is crucial for market access and client retention. This includes drug master files (DMFs) and certificates of analysis (CoAs).
  • Supply Chain Resilience: Building robust and diversified supply chains to mitigate risks of raw material shortages and ensure reliable delivery is a key focus.
  • Innovation in Application: Developing new formulations or application methods that enhance the performance or cost-effectiveness of FD&C Yellow No. 6 Aluminum Lake in specific pharmaceutical matrices.
  • Geographic Expansion: Targeting growth in emerging pharmaceutical markets through strategic partnerships or direct market penetration.

What is the Financial Trajectory and Profitability?

The financial trajectory for manufacturers of FD&C Yellow No. 6 Aluminum Lake is generally stable, tied to the steady growth of the pharmaceutical industry. Profitability is influenced by several factors:

  • Production Scale and Efficiency: Larger production volumes can lead to economies of scale, reducing per-unit manufacturing costs. Process optimization is critical.
  • Raw Material Costs: Fluctuations in the cost of key precursors directly impact gross margins. Hedging strategies or long-term supply contracts can help manage this.
  • Pricing Power: While competition exists, the highly regulated nature of pharmaceutical excipients can provide some pricing power for suppliers with strong regulatory compliance and a proven track record.
  • Value-Added Services: Companies offering extensive regulatory support, custom formulations, and reliable supply chain management can command higher prices.
  • Market Share: Dominant players with a significant portion of the market can benefit from consistent demand and established customer relationships.

Specific profit margins are proprietary information, but the overall excipient market is generally considered to be a mid-to-high margin sector due to the stringent quality and regulatory requirements. The financial performance of companies like Sensient Technologies, which includes pharmaceutical colorants in its portfolio, can offer an indicator of the broader market health, with segments catering to regulated industries demonstrating resilience.

Key Takeaways

  • FD&C Yellow No. 6 Aluminum Lake is an FDA-approved synthetic colorant critical for identifying and differentiating pharmaceutical products, primarily in solid oral dosage forms.
  • The market is driven by the expansion of the generic drug sector, increased focus on patient compliance, and product branding strategies.
  • Key challenges include volatile raw material costs, evolving regulatory demands, and competition from alternative colorants, including natural options.
  • Market leaders focus on ensuring product quality, regulatory compliance, supply chain reliability, and providing comprehensive client support.
  • The financial trajectory is stable, with profitability influenced by production efficiency, raw material sourcing, pricing power within the regulated excipient market, and the provision of value-added services.

Frequently Asked Questions

What is the difference between FD&C Yellow No. 6 and FD&C Yellow No. 6 Aluminum Lake?

FD&C Yellow No. 6 is a water-soluble azo dye. FD&C Yellow No. 6 Aluminum Lake is formed by precipitating FD&C Yellow No. 6 onto an aluminum hydroxide substrate, making it water-insoluble and suitable for applications requiring dispersion rather than dissolution, such as tablet coatings.

Are there any known safety concerns with FD&C Yellow No. 6 Aluminum Lake in pharmaceuticals?

FD&C Yellow No. 6 Aluminum Lake is approved by the FDA for pharmaceutical use, meaning it has undergone safety reviews. Its use is subject to concentration limits and purity standards outlined in the Code of Federal Regulations. Like all approved colorants, ongoing surveillance and scientific evaluation continue.

How does the demand for natural colorants affect the market for synthetic lakes like FD&C Yellow No. 6 Aluminum Lake?

The growing demand for "clean label" products has led to increased interest in natural colorants. While this presents a competitive challenge, synthetic lakes like FD&C Yellow No. 6 Aluminum Lake maintain a strong position due to their superior stability, color consistency, and cost-effectiveness in many pharmaceutical applications where performance and regulatory approval are paramount.

What is the typical shelf life of FD&C Yellow No. 6 Aluminum Lake when used in pharmaceutical formulations?

The shelf life is dependent on the specific formulation and storage conditions of the finished pharmaceutical product. However, FD&C Yellow No. 6 Aluminum Lake itself is a stable pigment. Manufacturers provide specifications regarding its stability under recommended storage conditions, typically in a cool, dry place, protected from light.

What are the primary regulatory bodies governing the use of FD&C Yellow No. 6 Aluminum Lake in pharmaceuticals globally?

In the United States, the Food and Drug Administration (FDA) governs its use. Globally, other major regulatory bodies such as the European Medicines Agency (EMA) in Europe, Health Canada, and the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan, among others, set their own standards and approvals for pharmaceutical colorants.

Citations

[1] Mordor Intelligence. (2023). Pharmaceutical Excipients Market - Growth, Trends, COVID-19 Impact, and Forecasts (2024 - 2029). Retrieved from [Mordor Intelligence website or specific report page if available and cited by author].

[2] Global Market Insights. (2023). Generic Drugs Market Size, Share & Trends Analysis Report By Drug Type, By Distribution Channel, By Therapeutic Area, By Region, And Segment Forecasts, 2023 - 2030. Retrieved from [Global Market Insights website or specific report page if available and cited by author].

[3] Patel, M. H., & Patel, G. (2019). Pharmaceutical excipients: A review. International Journal of Pharmacy and Pharmaceutical Sciences, 11(8), 1-8.

[4] U.S. Food and Drug Administration. (2022). Color Additives: FDA Approval Process. Retrieved from [FDA website - Specific page on color additive approval process].

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.